Reaction Biology

United States Founded: 2001 • Age: 25 yrs
In vitro enzyme activity assays, secializing in kinase epigenetic HTS and profiling
Request Access

About Reaction Biology

Reaction Biology is a company based in United States founded in 2001.. The company has 77 employees as of December 31, 2021. Reaction Biology has completed 3 acquisitions, including Bioassay, Peptide Specialty Laboratories and ProQinase. Reaction Biology operates in a competitive market with competitors including Chroma Medicine, FOXO Technologies, ImmunoSCAPE, PhenoVista and Chronomics, among others.

  • Headquarter United States
  • Employees 77 as on 31 Dec, 2021
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Reaction Biology Europe Gmbh
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
    HHS

    & 4 more

  • Employee Count
    77

    as on Dec 31, 2021

  • Investments & Acquisitions
    Bioassay

    & 2 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Reaction Biology
Headcount 50-200
Employee Profiles 17
Employee Profiles
People
Ekaterina Kuznetsova
Senior Director of Product Development, USA
People
Cynthia Obodozie
Head of In Vivo Pharmacology Project Management & Animal Affairs
People
Safnas F. Abdulsalam
Director of Assay Development, USA
People
Richard S. Kollender
CFO & Chief Business Officer

Unlock access to complete

Funding Insights of Reaction Biology

  • Total Funding
  • Total Rounds 16
  • Last Round
  • First Round

    (09 Aug 2005)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2022 Amount Private Equity Round - Reaction Biology Valuation Cobepa
Apr, 2016 Amount Grant - Reaction Biology Valuation

investors

HHS
Jul, 2014 Amount Grant - Reaction Biology Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Reaction Biology

Reaction Biology has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, National Cancer Institute and Cobepa. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Cobepa is recognized as an independent investment company.
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Research is conducted to advance translational science for health solutions.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Reaction Biology

Reaction Biology has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Bioassay, Peptide Specialty Laboratories and ProQinase. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Biological assays for pharmaceutical and chemical products are specialized in.
2002
Contract research company for cancer drug discovery
2001
Medical research lab services in peptide specialties are provided.
2000
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Reaction Biology

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Reaction Biology Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Reaction Biology

Reaction Biology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Chroma Medicine, FOXO Technologies, ImmunoSCAPE, PhenoVista and Chronomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Epigenetic editing platform is developed for genomic medicines.
domain founded_year HQ Location
Epigenetic biomarkers are discovered and developed via AI platforms.
domain founded_year HQ Location
High-dimensional immune profiling services are delivered via proprietary platform.
domain founded_year HQ Location
A CRO that provides phenotypic assay development and screening services.
domain founded_year HQ Location
Proactive healthcare analysis is enabled by DNA-based epigenetic tests.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Reaction Biology

When was Reaction Biology founded?

Reaction Biology was founded in 2001 and raised its 1st funding round 4 years after it was founded.

Where is Reaction Biology located?

Reaction Biology is headquartered in United States.

How many employees does Reaction Biology have?

As of Dec 31, 2021, the latest employee count at Reaction Biology is 77.

What does Reaction Biology do?

Reaction Biology was founded in 2001 in the United States as a contract research organization focused on biotechnology. In vitro enzyme activity assays are offered for high-throughput screening and profiling, with specialization in kinase, epigenetic regulatory enzymes, and protease activities. Services include compound library screening, cell-based assays, CYP and hERG profiling, custom assay development, and protein microarray applications, supporting drug discovery efforts across various therapeutic areas.

Who are the top competitors of Reaction Biology?

Reaction Biology's top competitors include Chroma Medicine, FOXO Technologies and ImmunoSCAPE.

How many acquisitions has Reaction Biology made?

Reaction Biology has made 3 acquisitions, including Bioassay, Peptide Specialty Laboratories, and ProQinase.

Who are Reaction Biology's investors?
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available